Skip to main content
PMC home page
Annals of Surgery logoLink to Annals of Surgery
. 1999 Apr;229(4):467–477. doi: 10.1097/00000658-199904000-00004

Enteral nutritional supplementation with key nutrients in patients with critical illness and cancer: a meta-analysis of randomized controlled clinical trials.

S D Heys 1, L G Walker 1, I Smith 1, O Eremin 1
PMCID: PMC1191731  PMID: 10203078

Abstract

OBJECTIVE: To conduct a meta-analysis of 11 randomized controlled trials comparing enteral nutritional support supplemented with key nutrients versus standard enteral nutritional support to determine effects on morbidity and mortality rates and hospital stay. BACKGROUND DATA: Recent studies have shown that malnutrition occurs in up to 30% of patients undergoing gastrointestinal surgery, resulting in an increased risk of postoperative complications and death. With the realization that key nutrients can modulate inflammatory, metabolic, and immune processes, enteral nutritional regimens (supplemented with large amounts of key nutrients) have been developed for clinical use. METHODS: Eleven prospective, randomized controlled trials evaluating 1009 patients treated with combinations of key nutrients (Impact, Immun-Aid) were evaluated. Outcome measures examined were the incidences of pneumonia, infectious complications, and death, and length of hospital stay. Meta-analyses were undertaken to obtain the odds ratio and 95% confidence interval for incidences of infectious complications, pneumonia, and death, and the weighted mean difference and 95% confidence interval for length of hospital stay. RESULTS: The provision of nutritional support supplemented with key nutrients to patients with critical illness resulted in a decrease in infectious complications when compared with patients receiving standard nutritional support and a significant reduction in overall hospital stay. Similar results were documented in patients with gastrointestinal cancer. However, there were no differences between patient groups for either pneumonia or death. CONCLUSIONS: This meta-analysis has demonstrated that nutritional support supplemented with key nutrients results in a significant reduction in the risk of developing infectious complications and reduces the overall hospital stay in patients with critical illness and in patients with gastrointestinal cancer. However, there is no effect on death. These data have important implications for the management of such patients.

Full text

PDF
468

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alexander J. W., Saito H., Trocki O., Ogle C. K. The importance of lipid type in the diet after burn injury. Ann Surg. 1986 Jul;204(1):1–8. doi: 10.1097/00000658-198607000-00001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Barbul A., Lazarou S. A., Efron D. T., Wasserkrug H. L., Efron G. Arginine enhances wound healing and lymphocyte immune responses in humans. Surgery. 1990 Aug;108(2):331–337. [PubMed] [Google Scholar]
  3. Begg C., Cho M., Eastwood S., Horton R., Moher D., Olkin I., Pitkin R., Rennie D., Schulz K. F., Simel D. Improving the quality of reporting of randomized controlled trials. The CONSORT statement. JAMA. 1996 Aug 28;276(8):637–639. doi: 10.1001/jama.276.8.637. [DOI] [PubMed] [Google Scholar]
  4. Bower R. H., Cerra F. B., Bershadsky B., Licari J. J., Hoyt D. B., Jensen G. L., Van Buren C. T., Rothkopf M. M., Daly J. M., Adelsberg B. R. Early enteral administration of a formula (Impact) supplemented with arginine, nucleotides, and fish oil in intensive care unit patients: results of a multicenter, prospective, randomized, clinical trial. Crit Care Med. 1995 Mar;23(3):436–449. doi: 10.1097/00003246-199503000-00006. [DOI] [PubMed] [Google Scholar]
  5. Braga M., Gianotti L., Vignali A., Cestari A., Bisagni P., Di Carlo V. Artificial nutrition after major abdominal surgery: impact of route of administration and composition of the diet. Crit Care Med. 1998 Jan;26(1):24–30. doi: 10.1097/00003246-199801000-00012. [DOI] [PubMed] [Google Scholar]
  6. Braga M., Vignali A., Gianotti L., Cestari A., Profili M., Di Carlo V. Benefits of early postoperative enteral feeding in cancer patients. Infusionsther Transfusionsmed. 1995 Oct;22(5):280–284. doi: 10.1159/000223143. [DOI] [PubMed] [Google Scholar]
  7. Brittenden J., Park K. G., Heys S. D., Ross C., Ashby J., Ah-See A. k., Eremin O. L-arginine stimulates host defenses in patients with breast cancer. Surgery. 1994 Feb;115(2):205–212. [PubMed] [Google Scholar]
  8. Burns L. R., Wholey D. R. The effects of patient, hospital, and physician characteristics on length of stay and mortality. Med Care. 1991 Mar;29(3):251–271. doi: 10.1097/00005650-199103000-00007. [DOI] [PubMed] [Google Scholar]
  9. Cerra F. B., Lehman S., Konstantinides N., Konstantinides F., Shronts E. P., Holman R. Effect of enteral nutrient on in vitro tests of immune function in ICU patients: a preliminary report. Nutrition. 1990 Jan-Feb;6(1):84–98. [PubMed] [Google Scholar]
  10. Collins R., Langman M. Treatment with histamine H2 antagonists in acute upper gastrointestinal hemorrhage. Implications of randomized trials. N Engl J Med. 1985 Sep 12;313(11):660–666. doi: 10.1056/NEJM198509123131104. [DOI] [PubMed] [Google Scholar]
  11. D'Agostino R. B., Weintraub M. Meta-analysis: a method for synthesizing research. Clin Pharmacol Ther. 1995 Dec;58(6):605–616. doi: 10.1016/0009-9236(95)90016-0. [DOI] [PubMed] [Google Scholar]
  12. Daly J. M., Lieberman M. D., Goldfine J., Shou J., Weintraub F., Rosato E. F., Lavin P. Enteral nutrition with supplemental arginine, RNA, and omega-3 fatty acids in patients after operation: immunologic, metabolic, and clinical outcome. Surgery. 1992 Jul;112(1):56–67. [PubMed] [Google Scholar]
  13. Daly J. M., Weintraub F. N., Shou J., Rosato E. F., Lucia M. Enteral nutrition during multimodality therapy in upper gastrointestinal cancer patients. Ann Surg. 1995 Apr;221(4):327–338. doi: 10.1097/00000658-199504000-00002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Detsky A. S., Naylor C. D., O'Rourke K., McGeer A. J., L'Abbé K. A. Incorporating variations in the quality of individual randomized trials into meta-analysis. J Clin Epidemiol. 1992 Mar;45(3):255–265. doi: 10.1016/0895-4356(92)90085-2. [DOI] [PubMed] [Google Scholar]
  15. Elebute E. A., Stoner H. B. The grading of sepsis. Br J Surg. 1983 Jan;70(1):29–31. doi: 10.1002/bjs.1800700111. [DOI] [PubMed] [Google Scholar]
  16. Garner J. S., Jarvis W. R., Emori T. G., Horan T. C., Hughes J. M. CDC definitions for nosocomial infections, 1988. Am J Infect Control. 1988 Jun;16(3):128–140. doi: 10.1016/0196-6553(88)90053-3. [DOI] [PubMed] [Google Scholar]
  17. Heys S. D., Gough D. B., Khan L., Eremin O. Nutritional pharmacology and malignant disease: a therapeutic modality in patients with cancer. Br J Surg. 1996 May;83(5):608–619. doi: 10.1002/bjs.1800830508. [DOI] [PubMed] [Google Scholar]
  18. Heys S. D., Ogston K., Miller I., Hutcheon A. W., Walker L. G., Sarker T. K., Dewar J., Ah-See A. K., Eremin O. Potentiation of the response to chemotherapy in patients with breast cancer by dietary supplementation with L-arginine: results of a randomised controlled trial. Int J Oncol. 1998 Jan;12(1):221–225. doi: 10.3892/ijo.12.1.221. [DOI] [PubMed] [Google Scholar]
  19. Heys S. D., Park K. G., Garlick P. J., Eremin O. Nutrition and malignant disease: implications for surgical practice. Br J Surg. 1992 Jul;79(7):614–623. doi: 10.1002/bjs.1800790707. [DOI] [PubMed] [Google Scholar]
  20. Kemen M., Senkal M., Homann H. H., Mumme A., Dauphin A. K., Baier J., Windeler J., Neumann H., Zumtobel V. Early postoperative enteral nutrition with arginine-omega-3 fatty acids and ribonucleic acid-supplemented diet versus placebo in cancer patients: an immunologic evaluation of Impact. Crit Care Med. 1995 Apr;23(4):652–659. doi: 10.1097/00003246-199504000-00012. [DOI] [PubMed] [Google Scholar]
  21. Khan A. L., Heys S. D., Eremin O. Synthetic polyribonucleotides: current role and potential use in oncological practice. Eur J Surg Oncol. 1995 Apr;21(2):224–227. doi: 10.1016/s0748-7983(95)90930-3. [DOI] [PubMed] [Google Scholar]
  22. Khan A. L., Richardson S., Drew J., Larsen F., Campbell M., Heys S. D., Ah-See A. K., Eremin O. Polyadenylic-polyuridylic acid enhances the natural cell-mediated cytotoxicity in patients with breast cancer undergoing mastectomy. Surgery. 1995 Sep;118(3):531–538. doi: 10.1016/s0039-6060(05)80370-8. [DOI] [PubMed] [Google Scholar]
  23. Klein S., Kinney J., Jeejeebhoy K., Alpers D., Hellerstein M., Murray M., Twomey P. Nutrition support in clinical practice: review of published data and recommendations for future research directions. National Institutes of Health, American Society for Parenteral and Enteral Nutrition, and American Society for Clinical Nutrition. JPEN J Parenter Enteral Nutr. 1997 May-Jun;21(3):133–156. doi: 10.1177/0148607197021003133. [DOI] [PubMed] [Google Scholar]
  24. Kudsk K. A., Minard G., Croce M. A., Brown R. O., Lowrey T. S., Pritchard F. E., Dickerson R. N., Fabian T. C. A randomized trial of isonitrogenous enteral diets after severe trauma. An immune-enhancing diet reduces septic complications. Ann Surg. 1996 Oct;224(4):531–543. doi: 10.1097/00000658-199610000-00011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Laird N. M., Mosteller F. Some statistical methods for combining experimental results. Int J Technol Assess Health Care. 1990;6(1):5–30. doi: 10.1017/s0266462300008916. [DOI] [PubMed] [Google Scholar]
  26. MANTEL N., HAENSZEL W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959 Apr;22(4):719–748. [PubMed] [Google Scholar]
  27. Mendez C., Jurkovich G. J., Garcia I., Davis D., Parker A., Maier R. V. Effects of an immune-enhancing diet in critically injured patients. J Trauma. 1997 May;42(5):933–941. doi: 10.1097/00005373-199705000-00026. [DOI] [PubMed] [Google Scholar]
  28. Meydani S. N., Endres S., Woods M. M., Goldin B. R., Soo C., Morrill-Labrode A., Dinarello C. A., Gorbach S. L. Oral (n-3) fatty acid supplementation suppresses cytokine production and lymphocyte proliferation: comparison between young and older women. J Nutr. 1991 Apr;121(4):547–555. doi: 10.1093/jn/121.4.547. [DOI] [PubMed] [Google Scholar]
  29. Moore F. A., Moore E. E., Kudsk K. A., Brown R. O., Bower R. H., Koruda M. J., Baker C. C., Barbul A. Clinical benefits of an immune-enhancing diet for early postinjury enteral feeding. J Trauma. 1994 Oct;37(4):607–615. doi: 10.1097/00005373-199410000-00014. [DOI] [PubMed] [Google Scholar]
  30. O'Riordain M. G., Fearon K. C., Ross J. A., Rogers P., Falconer J. S., Bartolo D. C., Garden O. J., Carter D. C. Glutamine-supplemented total parenteral nutrition enhances T-lymphocyte response in surgical patients undergoing colorectal resection. Ann Surg. 1994 Aug;220(2):212–221. doi: 10.1097/00000658-199408000-00014. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Park K. G., Heys S. D., Blessing K., Kelly P., McNurlan M. A., Eremin O., Garlick P. J. Stimulation of human breast cancers by dietary L-arginine. Clin Sci (Lond) 1992 Apr;82(4):413–417. doi: 10.1042/cs0820413. [DOI] [PubMed] [Google Scholar]
  32. Perioperative total parenteral nutrition in surgical patients. The Veterans Affairs Total Parenteral Nutrition Cooperative Study Group. N Engl J Med. 1991 Aug 22;325(8):525–532. doi: 10.1056/NEJM199108223250801. [DOI] [PubMed] [Google Scholar]
  33. Purasiri P., Ashby J., Heys S. D., Eremin O. Effect of essential fatty acids on circulating T cell subsets in patients with colorectal cancer. Cancer Immunol Immunother. 1994 Oct;39(4):217–222. doi: 10.1007/BF01525984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Purasiri P., Mckechnie A., Heys S. D., Eremin O. Modulation in vitro of human natural cytotoxicity, lymphocyte proliferative response to mitogens and cytokine production by essential fatty acids. Immunology. 1997 Oct;92(2):166–172. doi: 10.1046/j.1365-2567.1997.d01-2308.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Purasiri P., Murray A., Richardson S., Heys S. D., Horrobin D., Eremin O. Modulation of cytokine production in vivo by dietary essential fatty acids in patients with colorectal cancer. Clin Sci (Lond) 1994 Dec;87(6):711–717. doi: 10.1042/cs0870711. [DOI] [PubMed] [Google Scholar]
  36. Saffle J. R., Wiebke G., Jennings K., Morris S. E., Barton R. G. Randomized trial of immune-enhancing enteral nutrition in burn patients. J Trauma. 1997 May;42(5):793–802. doi: 10.1097/00005373-199705000-00008. [DOI] [PubMed] [Google Scholar]
  37. Schilling J., Vranjes N., Fierz W., Joller H., Gyurech D., Ludwig E., Marathias K., Geroulanos S. Clinical outcome and immunology of postoperative arginine, omega-3 fatty acids, and nucleotide-enriched enteral feeding: a randomized prospective comparison with standard enteral and low calorie/low fat i.v. solutions. Nutrition. 1996 Jun;12(6):423–429. doi: 10.1016/s0899-9007(96)00096-2. [DOI] [PubMed] [Google Scholar]
  38. Senkal M., Mumme A., Eickhoff U., Geier B., Späth G., Wulfert D., Joosten U., Frei A., Kemen M. Early postoperative enteral immunonutrition: clinical outcome and cost-comparison analysis in surgical patients. Crit Care Med. 1997 Sep;25(9):1489–1496. doi: 10.1097/00003246-199709000-00015. [DOI] [PubMed] [Google Scholar]
  39. Stehle P., Zander J., Mertes N., Albers S., Puchstein C., Lawin P., Fürst P. Effect of parenteral glutamine peptide supplements on muscle glutamine loss and nitrogen balance after major surgery. Lancet. 1989 Feb 4;1(8632):231–233. doi: 10.1016/s0140-6736(89)91254-3. [DOI] [PubMed] [Google Scholar]
  40. Ziegler T. R., Young L. S., Benfell K., Scheltinga M., Hortos K., Bye R., Morrow F. D., Jacobs D. O., Smith R. J., Antin J. H. Clinical and metabolic efficacy of glutamine-supplemented parenteral nutrition after bone marrow transplantation. A randomized, double-blind, controlled study. Ann Intern Med. 1992 May 15;116(10):821–828. doi: 10.7326/0003-4819-116-10-821. [DOI] [PubMed] [Google Scholar]

Articles from Annals of Surgery are provided here courtesy of Lippincott, Williams, and Wilkins

RESOURCES